-
Security Type
-
Equity
-
Categories
-
Other
-
Min Investment
-
$250
-
Offering Date
-
December 20, 2019
-
Expected Close Date
-
March 21, 2020
-
Target Raise
-
$10.00K-$1.07M
-
Deal Notes
-
Security Name: Common Stock
$1.00 per share
-
Valuation
-
$3,900,000
Company Description
CompanionCBD is a veterinarian-owned and operated company.
CBD can help manage anxiety, pain, seizures, neuro-degenerative conditions and more in pets. We Believe, the therapeutic potential of CBD in the marketplace—as it pertains to veterinary care, especially—is untapped. This is due to the current market’s fascination with CBD “treats,” none of which contain enough compound to provide real therapeutic benefits.
Our soft chew, while extremely palatable to the pet due to its cheesy-bread flavor, delivers science-based concentrations of CBD capable of producing tangible, documentable therapeutic results.
Perks
$500+ (Access to Owners group where you get early access to products, new releases and early feedback
$1,000 (100 in store credit)
$2,500+ (5% bonus shares + and $250 in store credit)
$5,000+ (10% bonus shares and $500 in store credit)
$20,000+ (15% bonus shares + $1,000 in store credit)
*All perks occur after the offering is completed
Key Deal Facts
Dr. Josh Sosnow pioneered the research, development, and education of CBD in the veterinary market.
Dr. Sosnow created one of the first Registry of Approved Continuing Education (RACE®)-approved series on CBD. Over 5000 veterinarians have taken the course.
Veterinarian-owned company with a proven track record of sales since Oct. 2018. Our products are veterinarian-approved and endorsed. Products are sold at veterinary hospitals and retailers alike across the US.
Use of Proceeds
Inventory, Marketing, Salaries, StartEngine Platform Fees
Management Team / Advisory Board Bios
Brad Malin
Co- Founder, CEO and Director
A serial entrepreneur with over 23 years of global sales, branding, marketing, distribution and consulting experience. Brad has worked in a number of different industries, ranging for medical technology, to real estate, biotech/Pharma, environmental and entertainment distribution.
Dr. Josh Sosnow
Co-founder, Chief medical officer, CFO and Director
A practicing veterinarian for over 19 years, and advocate for the clinical use of CBD in clinical practice, Dr. Josh Sosnow is a nationally-recognized CBD educator in the veterinary community. His Principal Occupation is President at Sosnow Animal Hospitals, P.C and works with CompanionCBD about 15-20 hours a week.
Deal Notes
Security Name: Common Stock
$1.00 per share
